These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 26579784

  • 1. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
    Abbott R, Smith DE.
    J Psychoactive Drugs; 2015; 47(5):368-71. PubMed ID: 26579784
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthetic cathinones ("bath salts").
    Banks ML, Worst TJ, Rusyniak DE, Sprague JE.
    J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
    [Abstract] [Full Text] [Related]

  • 4. Khat and synthetic cathinones: a review.
    Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M.
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [Abstract] [Full Text] [Related]

  • 5. Synthetic cathinones: "a khat and mouse game".
    Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M.
    Toxicol Lett; 2014 Sep 02; 229(2):349-56. PubMed ID: 24973490
    [Abstract] [Full Text] [Related]

  • 6. Cathinone neurotoxicity ("The "3Ms").
    Karch SB.
    Curr Neuropharmacol; 2015 Jan 02; 13(1):21-5. PubMed ID: 26074741
    [Abstract] [Full Text] [Related]

  • 7. Mephedrone and other cathinones.
    Zawilska JB.
    Curr Opin Psychiatry; 2014 Jul 02; 27(4):256-62. PubMed ID: 24852055
    [Abstract] [Full Text] [Related]

  • 8. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME, Hampton JP.
    Pharmacotherapy; 2014 Jul 02; 34(7):745-57. PubMed ID: 24710806
    [Abstract] [Full Text] [Related]

  • 9. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL.
    J Neurosci; 2014 Nov 12; 34(46):15150-8. PubMed ID: 25392483
    [Abstract] [Full Text] [Related]

  • 10. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB, Słomiak K, Wasiak M, Woźniak P, Massalski M, Krupa E, Wojcieszak JŁ.
    Przegl Lek; 2013 Nov 12; 70(6):386-91. PubMed ID: 24052975
    [Abstract] [Full Text] [Related]

  • 11. The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
    Meyers K, Kaynak Ö, Bresani E, Curtis B, McNamara A, Brownfield K, Kirby KC.
    Int J Drug Policy; 2015 Jul 12; 26(7):670-4. PubMed ID: 25641258
    [Abstract] [Full Text] [Related]

  • 12. Sudden cardiac death associated with methylone use.
    Carbone PN, Carbone DL, Carstairs SD, Luzi SA.
    Am J Forensic Med Pathol; 2013 Mar 12; 34(1):26-8. PubMed ID: 23403480
    [Abstract] [Full Text] [Related]

  • 13. Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.
    Ashrafioun L, Bonadio FA, Baik KD, Bradbury SL, Carhart VL, Cross NA, Davis AK, Feuille M, Harper AR, Lackey JH, Lang B, Lauritsen KJ, Leith J, Osborn LA, Rosenberg H, Stock J, Zaturenskaya M.
    J Psychoactive Drugs; 2016 Mar 12; 48(5):336-343. PubMed ID: 27681583
    [Abstract] [Full Text] [Related]

  • 14. [Cathinones use in Paris].
    Batisse A, Grégoire M, Marillier M, Fortias M, Djezzar S.
    Encephale; 2016 Aug 12; 42(4):354-60. PubMed ID: 26847479
    [Abstract] [Full Text] [Related]

  • 15. Beta-blocker use for toxicity from "bath salts".
    Richards JR, Laurin EG, Albertson TE.
    J Emerg Med; 2015 Feb 12; 48(2):e45-6. PubMed ID: 25453853
    [No Abstract] [Full Text] [Related]

  • 16. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL, Alves VL, Aguiar J, Teixeira HM, Câmara JS.
    Crit Rev Toxicol; 2019 Aug 12; 49(7):549-566. PubMed ID: 31747318
    [Abstract] [Full Text] [Related]

  • 17. The pharmacology and neurotoxicology of synthetic cathinones.
    Angoa-Perez M, Kuhn DM.
    Adv Pharmacol; 2024 Aug 12; 99():61-82. PubMed ID: 38467489
    [Abstract] [Full Text] [Related]

  • 18. Stimulant and Designer Drug Use: Primary Care Management.
    Klega AE, Keehbauch JT.
    Am Fam Physician; 2018 Jul 15; 98(2):85-92. PubMed ID: 30215997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
    Calinski DM, Kisor DF, Sprague JE.
    Psychopharmacology (Berl); 2019 Mar 15; 236(3):881-890. PubMed ID: 30069588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.